Bios, Chips, and Implants: Cybersecurity When the Endpoint Is a Human

When the “endpoint” is part of a person’s body, the stakes of cybersecurity change. In this narrated audio version of Bios, Chips, and Implants: Cybersecurity When the Endpoint Is a Human, we walk through how pacemakers, insulin pumps, exoskeletons, augmented reality headsets, and other bio-digital devices are already intersecting with your networks and decisions. You will hear how threat models evolve when attackers can seek leverage through harm, coercion, or intimate exposure, and why traditional endpoint thinking breaks down when devices cannot simply be reimaged or replaced. This episode is based on my Wednesday “Headline” feature from Bare Metal Cyber Magazine.

What is Bare Metal Cyber?

Welcome to Bare Metal Cyber, the podcast that bridges cybersecurity and education in a way that’s engaging, informative, and practical. Hosted by Dr. Jason Edwards, a seasoned cybersecurity expert and educator, this weekly podcast brings to life the insights, tips, and stories from his widely-read LinkedIn articles. Each episode dives into pressing cybersecurity topics, real-world challenges, and actionable advice to empower professionals, educators, and learners alike. Whether navigating the complexities of cyber defense or looking for ways to integrate cybersecurity into education, Bare Metal Cyber delivers valuable perspectives to help you stay ahead in an ever-evolving digital world. Subscribe and join the thousands already benefiting from Jason’s expertise!

The first time this kind of question appears, it rarely comes through a CISO dashboard. It is a plant engineer who cannot finish a shift because the exoskeleton on their back needs a firmware update. It is a senior leader with a cardiac implant asking whether airport-style scanners are safe. It is a manager wondering if new smart safety helmets can connect to the factory Wi-Fi.

In that moment, all the familiar diagrams of laptops, phones, cloud workloads, and corporate networks collide with a different reality. Some of the endpoints that matter most to your organization now sit on skin or under it.

You are listening to a Wednesday Headline feature from Bare Metal Cyber Magazine, developed by Bare Metal Cyber. This is about what happens when cybersecurity decisions reach all the way into human bodies.

Over the next few years, more of the compute that matters to your business will sit one Bluetooth hop away from someone’s heart, nerves, or bones. Pacemakers, insulin pumps, neurostimulators, and prosthetics are already inside your buildings, whether your asset inventory sees them or not.

So are augmented reality headsets on field technicians, smart badges and wearables for safety monitoring, and powered exoskeletons in warehouses and plants. Some connect through personal phones. Some connect through corporate tablets. Some use dedicated wireless networks that overlap with your own environment.

You may not have bought these devices, but your networks, policies, and incident playbooks wrap around them anyway.

Once you accept that, the threat model changes. The familiar concerns of confidentiality, integrity, and availability do not disappear. But the consequences move beyond financial loss and downtime. They can involve bodily harm, coercion, privacy invasion, and psychological pressure.

A manipulated sensor feed from an exoskeleton is not just a bad data point. It can influence how a worker moves in a hazardous environment. A compromised programming console for cardiac implants is not just another vulnerable workstation. It may represent the ability to alter therapy for people who sit in your boardroom, work in your plant, or walk through your facilities.

Even when the device itself is out of reach, the data it produces can be weaponized. Health signals, location patterns, therapy schedules, fatigue indicators, and movement data can be used to track people, infer medical conditions, or pressure key staff.

For targeted adversaries, certain people become composite targets. A senior executive with a medical implant, smart watch, phone, and wearable badge is no longer just an email address and calendar. They are a cluster of bio-digital dependencies.

Their sleep patterns, therapy rhythms, movements, and physical locations may all become potential levers.

In more opportunistic campaigns, attackers do not need deep medical expertise. They only need enough understanding to make a threat feel credible. A ransom demand that says, “pay or lose access to the CRM,” lands one way. A demand that says, “pay or we disrupt the device that keeps someone alive,” lands very differently.

The practical implication is that safety, privacy, and cyber operations can no longer live in separate conversations. Threat models that look only at servers, applications, and traditional endpoints are incomplete.

Leaders need to ask not only which systems an attacker can reach, but which human functions those systems influence. They need to consider how that influence changes extortion risk, regulatory exposure, workplace safety, and trust.

At an architectural level, the key move is to think in terms of bio-digital boundaries. Most implants and critical medical devices are not yours to manage. You cannot enroll a pacemaker into endpoint protection. You cannot force multifactor authentication onto a neurostimulator. You cannot patch an insulin pump every Tuesday.

What you can manage are the interfaces around them.

You define how companion apps on corporate phones authenticate. You decide which networks smart safety gear can join. You isolate programming consoles. You control which identity flows allow people to act on systems connected to body-adjacent devices.

You do not own the organ, but you help design the corridor it uses to communicate with the rest of your world.

In practice, that corridor may require special-handling zones in your architecture. Wireless networks used by safety wearables should be segmented with tightly controlled paths into core systems. Companion apps that manage medical devices from corporate phones need constrained entitlements and heightened monitoring. Shared programming consoles should live in hardened environments with strong access control and auditing, because one misused session can affect many people.

You still apply familiar principles like least privilege and segmentation. But the privilege you are controlling is no longer just access to data. It may be the ability to influence a person’s body.

Equally important is deciding what you will not do. The more signals these devices create, the easier it becomes to justify collecting everything in the name of safety, productivity, or optimization. That path quickly leads to surveillance creep and new liability.

A sustainable strategy defines clear no-go areas. Decide what body-derived data you will not store, even if it seems useful. Draw bright lines around controls you will not attempt to enforce on implants. Clarify which operational actions involving medical or body-adjacent devices will never happen without medical oversight.

Those boundaries are not just ethical gestures. They are anchors you can point to when employees, regulators, or partners ask how far your security program will reach into people’s lives.

Employment and consent issues arrive quickly once you start asking these questions. Some workers already rely on connected medical devices to function day to day. Others may be encouraged, or quietly pressured, to use smart badges, wearables, or exoskeletons framed as safety or productivity tools.

A policy may say participation is voluntary, but real pressure can appear in shift assignments, promotion conversations, and access to sensitive work. Traditional bring-your-own-device language written for phones and tablets does not translate cleanly when the device is under someone’s skin or prescribed by a doctor.

This means the risk register now includes employment law, disability accommodation, workplace trust, and safety culture. If you require biometric telemetry to enter high-risk zones, what happens to employees who cannot or will not wear those devices? If you analyze health-adjacent signals to infer fatigue or impairment, will that data be used only for safety, or also for discipline and performance management?

The same telemetry that helps prevent an accident can also be used to micromanage or discriminate. That dual use is exactly the kind of pattern regulators, unions, and courts will examine.

A credible approach starts with plain language and predictable processes. People should understand what bio-digital data you collect, why you collect it, who can see it, how long it is kept, and what rights they have to refuse or challenge its use.

Workers who depend on implants should have clear ways to request accommodations when a security control conflicts with medical advice. They should also have confidence that corporate security tooling will not be used to override their clinicians.

Human resources, legal, health and safety, and security need to be visibly aligned. Employees should not have to navigate conflicting messages when their body and livelihood are both involved.

The vendor landscape adds more complexity. Implantable and life-sustaining devices operate on timelines that make normal IT asset planning look short. A cardiac device or neurostimulator may remain in service for a decade, while phones, operating systems, and networks around it change several times.

Firmware updates may be rare, risky, or tightly regulated. In some cases, the only meaningful fix for a severe vulnerability is device replacement, which may involve surgery, insurance, and clinical judgment.

That means you cannot manage this risk with the same playbook you use for laptops and servers.

Vendor transparency can also be uneven. Many medical device ecosystems rely on proprietary protocols, closed management stacks, and tightly controlled diagnostics. Their assurance reports may be written for hospitals and regulators, not for factories, financial institutions, or technology companies with employees who use implants or wearables.

Instead of asking vendors, “are you secure,” ask more specific questions. How do you handle long-tail vulnerabilities on deployed devices? What assumptions do you make about companion app isolation? How do you communicate incidents that involve both clinical risk and corporate networks? What role will you play in joint investigations?

Procurement and third-party risk teams should treat bio-digital exposure as a standard evaluation category, not a strange edge case. Board reporting should connect these issues to duty of care, operational resilience, workforce trust, and safety.

In the end, treating humans as endpoints is not about inventing an entirely new security discipline. It is about threading bio-digital thinking into the work you already do, while being clear about where your responsibility stops and where it intensifies.

When you run tabletop exercises, include a scenario where ransomware threatens to expose implant data or disrupt therapy. When you review a new architecture, ask where body-adjacent devices touch the design. When you brief the board, include an example where a person’s health dependency changes how you think about extortion, availability, or vendor failure.

Then, when a plant engineer asks about an exoskeleton update, or an executive asks about a cardiac device, you will not be improvising your way through a conversation that was always coming.

You will have a mental model, a set of boundaries, and a shared language with your peers. You will know which controls are non-negotiable and which actions are off the table, even when they seem attractive during a crisis.

And you will be able to say honestly that your organization does not treat human bodies as just another asset class, even as it accepts that some of the most important endpoints it depends on now live in flesh and bone.